WallStreetZenWallStreetZen

NASDAQ: AXGN
Axogen Inc Stock Forecast, Predictions & Price Target

Analyst price target for AXGN

Based on 3 analysts offering 12 month price targets for Axogen Inc.
Min Forecast
$9.00+15.83%
Avg Forecast
$10.67+37.28%
Max Forecast
$12.00+54.44%

Should I buy or sell AXGN stock?

Based on 3 analysts offering ratings for Axogen Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AXGN stock forecasts and price targets.

AXGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-19
lockedlocked$00.00+00.00%2023-12-07
lockedlocked$00.00+00.00%2023-10-16

1 of 1

Forecast return on equity

Is AXGN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is AXGN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AXGN revenue forecast

What is AXGN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$179.1M+12.6%
Avg 2 year Forecast
$201.0M+26.37%
Avg 3 year Forecast
$222.4M+39.83%
AXGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AXGN revenue growth forecast

How is AXGN forecast to perform vs Medical Devices companies and vs the US market?
Company
11.84%
Industry
8.09%
Market
10.52%
AXGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AXGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AXGN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AXGN$7.77$10.67+37.28%Strong Buy
CATX$1.20$1.27+5.58%Strong Buy
CERS$1.79$2.75+53.63%Buy
LUNG$9.11$15.40+69.05%Strong Buy
VMD$9.38N/AN/A

Axogen Stock Forecast FAQ

Is Axogen Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: AXGN) stock is to Strong Buy AXGN stock.

Out of 3 analysts, 2 (66.67%) are recommending AXGN as a Strong Buy, 1 (33.33%) are recommending AXGN as a Buy, 0 (0%) are recommending AXGN as a Hold, 0 (0%) are recommending AXGN as a Sell, and 0 (0%) are recommending AXGN as a Strong Sell.

If you're new to stock investing, here's how to buy Axogen stock.

What is AXGN's revenue growth forecast for 2024-2026?

(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 11.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Axogen's revenue in 2024 is $159,012,000.On average, 2 Wall Street analysts forecast AXGN's revenue for 2024 to be $7,736,078,346, with the lowest AXGN revenue forecast at $7,733,918,034, and the highest AXGN revenue forecast at $7,738,238,659. On average, 2 Wall Street analysts forecast AXGN's revenue for 2025 to be $8,682,295,134, with the lowest AXGN revenue forecast at $8,654,211,074, and the highest AXGN revenue forecast at $8,710,379,194.

In 2026, AXGN is forecast to generate $9,606,908,798 in revenue, with the lowest revenue forecast at $9,604,748,486 and the highest revenue forecast at $9,609,069,110.

What is AXGN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AXGN) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is AXGN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AXGN price target, the average AXGN price target is $10.67, with the highest AXGN stock price forecast at $12.00 and the lowest AXGN stock price forecast at $9.00.

On average, Wall Street analysts predict that Axogen's share price could reach $10.67 by Jan 19, 2025. The average Axogen stock price prediction forecasts a potential upside of 37.28% from the current AXGN share price of $7.77.

What is AXGN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AXGN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.